Indo Amines Intrinsic Value
Indo Amines (INDOAMIN) median intrinsic value is ₹131.04 from 9 valuation models (range ₹70–₹281), vs current price ₹140.40 — -6.7% downside (Trading Near Calculated Value), margin of safety -7.1%. For current market price and key ratios, visit INDOAMIN share price screener.
INDOAMIN Valuation Methods Summary — DCF, Graham Number & P/E
Indo Amines intrinsic value across 9 models vs current price ₹140.40 — upside/downside and value range per method. Browse INDOAMIN balance sheet details for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹131.04 | ₹104.83 - ₹157.25 | -6.7% | EPS: ₹10.92, Sector P/E: 12x |
| Book Value Method | asset | ₹108.89 | ₹98.00 - ₹119.78 | -22.4% | Book Value/Share: ₹108.89, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹280.80 | ₹252.72 - ₹308.88 | +100.0% | Revenue/Share: ₹360.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹266.67 | ₹240.00 - ₹293.34 | +89.9% | EBITDA: ₹160.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹90.26 | ₹72.21 - ₹108.31 | -35.7% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹69.89 | ₹62.90 - ₹76.88 | -50.2% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹89.98 | ₹80.98 - ₹98.98 | -35.9% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹280.80 | ₹252.72 - ₹308.88 | +100.0% | ROE: 21.4%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹163.57 | ₹147.21 - ₹179.93 | +16.5% | EPS: ₹10.92, BVPS: ₹108.89 |
INDOAMIN Intrinsic Value vs Market Price — All Valuation Models
Indo Amines fair value range ₹70–₹281 vs current market price ₹140.40 across 9 valuation models. Also explore INDOAMIN share price data to track price trends across different timeframes.
INDOAMIN Intrinsic Value Analysis — Undervalued or Overvalued?
Indo Amines median intrinsic value ₹131.04, current price ₹140.40 — Trading Near Calculated Value by 6.7%, margin of safety -7.1%.
What is the intrinsic value of INDOAMIN?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Indo Amines (INDOAMIN) is ₹131.04 (median value). With the current market price of ₹140.40, this represents a -6.7% variance from our estimated fair value.
The valuation range spans from ₹69.89 to ₹280.80, indicating ₹69.89 - ₹280.80.
Is INDOAMIN undervalued or overvalued?
Based on our multi-method analysis, Indo Amines (INDOAMIN) appears to be trading near calculated value by approximately 6.7%.
INDOAMIN Financial Health — Key Ratios vs Industry Benchmarks
Indo Amines financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 5.46 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 21.4% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 11.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.44x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
INDOAMIN Cash Flow Quality — Operating & Free Cash Flow
Indo Amines operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹35 Cr | ₹-6 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹70 Cr | ₹57 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹20 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹16 Cr | ₹-4 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹56 Cr | ₹31 Cr | Positive Free Cash Flow | 8/10 |